ZEJULA (niraparib) Dosing and Adverse Reaction Management

Once-Daily Oral Dosing and Appropriate Dose Modification Support Long-Term Treatment With ZEJULA1

Explore dosing for ZEJULA in patients with ovarian cancer in the following treatment settings1:

shadow

ZEJULA: Once-daily oral dosing1

ZEJULA (niraparib) daily dosing schedule information
No specific drug-drug interactions have been reported with ZEJULA (niraparib)
No specific drug-drug interactions have been reported with ZEJULA (niraparib)

*No clinical drug interaction studies have been performed with ZEJULA.

Efficacy Data

View efficacy data for
all indications

SAFETY DATA

Learn about the safety
and tolerability of ZEJULA

Reference: 1. ZEJULA (niraparib). Prescribing Information. GlaxoSmithKline; 2021.